<DOC>
	<DOCNO>NCT02885818</DOCNO>
	<brief_summary>Abatacept disrupts T-cell coactivation signal rheumatoid arthritis ( RA ) . Its potential effect B cell well described . This study assess effect abatacept therapy phenotype function peripheral blood B cell patient RA .</brief_summary>
	<brief_title>Does Abatacept Induce Regulatory B Cells Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>RA define ACR/EULAR criterion Clinical indication start abatacept therapy Treatment rituximab previous year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>